Experienced in Aphthous Stomatitis

Armin Gerger

Graz, AT 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Aphthous Stomatitis
Graz, AT 
OverviewLocationsClinical Research

Overview

Armin Gerger practices in Graz, Austria. Mr. Gerger is rated as an Experienced expert by MediFind in the treatment of Aphthous Stomatitis. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Testicular Cancer, Adult Soft Tissue Sarcoma, and Tissue Biopsy.

His clinical research consists of co-authoring 166 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Aphthous Stomatitis.

Gender
Male

Locations

Graz, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) from Liquid And/or Tissue Biopsy in Patients with Locally Advanced And/or Metastatic Solid Cancer
Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) from Liquid And/or Tissue Biopsy in Patients with Locally Advanced And/or Metastatic Solid Cancer
Enrollment Status: Recruiting
Publish Date: March 14, 2025
Intervention Type: Genetic, Diagnostic test
Study Phase: Not Applicable
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 31, 2024
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
View 1 Less Clinical Trial

166 Total Publications

Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study.
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gerger's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile